Ataxia telangiectasia classification: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
== Classification == | == Classification == | ||
==Overview== | |||
There is no established system for the classification of [disease name]. | |||
OR | |||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | |||
OR | |||
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. | |||
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3]. | |||
OR | |||
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
If the staging system involves specific and characteristic findings and features: | |||
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
There is no established system for the staging of [malignancy name]. | |||
==Classification== | |||
There is no established system for the classification of [disease name]. | |||
OR | |||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | |||
*[Group1] | |||
*[Group2] | |||
*[Group3] | |||
*[Group4] | |||
OR | |||
[Disease name] may be classified into [large number > 6] subtypes based on: | |||
*[Classification method 1] | |||
*[Classification method 2] | |||
*[Classification method 3] | |||
[Disease name] may be classified into several subtypes based on: | |||
*[Classification method 1] | |||
*[Classification method 2] | |||
*[Classification method 3] | |||
OR | |||
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
'''If the staging system involves specific and characteristic findings and features:''' | |||
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
There is no established system for the staging of [malignancy name]. | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category: (name of the system)]] | |||
So far there appear to be three forms of AT: | So far there appear to be three forms of AT: |
Revision as of 14:42, 5 June 2020
Ataxia telangiectasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ataxia telangiectasia classification On the Web |
American Roentgen Ray Society Images of Ataxia telangiectasia classification |
Risk calculators and risk factors for Ataxia telangiectasia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Classification
Overview
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [Group1]
- [Group2]
- [Group3]
- [Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
[Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
References
So far there appear to be three forms of AT:
- Pure AT where patients present with all/most of the diagnostic symptoms.
- Attenuated AT where sufferers do not possess all of the diagnostic symptoms.
- Carrier AT where individuals with a single ATM mutation show an increased risk of cancer (known since the 1970’s).
These are sometimes classified into ‘types’ from I to IV.
- Type I is the classic syndrome with all manifestations.
- Type II lacks some of the typical findings but shows radiosensitivity.
- Type III has the classic clinical findings but is not radiosensitive.
- Type IV shows only some clinical features and is not radiosensitive.